| Robert Ellis Bonham, MD | |
|
4104 Junius St., Dallas, TX 75246 | |
| (214) 742-2194 | |
| (214) 827-0162 |
| Full Name | Robert Ellis Bonham |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 4104 Junius St., Dallas, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649264359 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | D3155 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Ellis Bonham, MD 4104 Junius St., Dallas, TX 75246 Ph: (214) 742-2194 | Robert Ellis Bonham, MD 4104 Junius St., Dallas, TX 75246 Ph: (214) 742-2194 |
News Archive
Premier Insurance Management Services Inc. (PIMS) has returned more than $104,000 in experience credit payments to 27 Premier healthcare alliance member hospitals and healthcare systems that participate in the PIMS Fidelity and Fiduciary Liability sponsored insurance program.
As the days grow longer and hotter, some chemical dependency professionals have their own name for summer: substance abuse season, because that's when individuals who abuse or are addicted to alcohol, prescription medications and drugs get involved in alcohol or drug related accidents during the summer holidays.
Abiraterone has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel.
The Washington Post provides highlights from the Washington Post Live "Future of Food: Food Security in the 21st Century" summit that was held on June 14 and "attracted many of the best minds devoted to solving the problem of feeding the world's ever-growing population."
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has received clearance from the U.K. Medicines and Healthcare products Regulatory Agency to begin treating patients as part of a Phase 1/2 clinical trial for Stargardt's Macular Dystrophy using retinal pigment epithelium (RPE) derived from human embryonic stem cells.
› Verified 2 days ago
Dr. Anthony Michael Tolisano, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3102 | |
Presley M. Mock, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8440 Walnut Hill Ln, Ste 500, Dallas, TX 75231 Phone: 214-345-1491 Fax: 214-345-5708 | |
Dr. Jane Farrar Admire, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7777 Forest Ln, Suite C-100, Dallas, TX 75230 Phone: 972-566-4848 | |
Chung-en Huang, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3430 W Wheatland Rd Ste 209, Dallas, TX 75237 Phone: 972-780-1496 Fax: 972-709-1496 | |
Dr. Seckin Omer Ulualp, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 214-456-2905 | |
Dr. Kenneth H Lee, M.D., PH.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd., Ut Soutwestern Otolaryngology, Dallas, TX 45229 Phone: 214-648-2972 Fax: 214-648-9122 | |
Jacob Boston Hunter, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-8898 Fax: 214-645-8894 |